{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:14Z","timestamp":1790799974789,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to investigate the homogeneity of the major salivary glands in multiple sclerosis (MS) patients using ultrasonography (USG), assess DMFT indices, measure resting salivary flow rates, and compare these values with healthy individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, 20 individuals diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS) (mean age 36.15\u2009\u00b1\u20098.51) and 20 systemically healthy individuals (mean age 35.7\u2009\u00b1\u20099.22) were included. Oral and radiologic examinations were performed in all individuals. The parotid and submandibular salivary glands were examined using USG, and their homogeneity was assessed based on the scoring system recommended by the Outcome Measures in Rheumatology Clinical Trials (OMERACT) study group. Resting salivary flow rates and DMFT indices were measured, and the obtained data were subjected to statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The parotid glands exhibited more heterogeneity on USG within the MS patient group than the control group, with a statistically significant difference between the two groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015). A statistically significant correlation was observed in total homogeneity values between the patient and control groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021). Furthermore, the MS patient group exhibited higher DMFT indices and lower salivary flow rates than the control group. The difference between the DMFT indices and salivary flow rate between the patient groups was statistically significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002 respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The parenchyma of the major salivary glands in MS patients exhibited decreased homogeneity than the healthy controls. Additionally, the MS group showed a decrease in salivary flow rate and an increase in the DMFT index. Autonomic dysfunction and medications used for MS are thought to cause salivary gland hypofunction and dry mouth. It can be interpreted that hyposalivation and motor skill losses in MS patients lead to an increase in DMFT index.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12903-024-04007-0","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:02:55Z","timestamp":1708070575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of major salivary glands with ultrasonography in multiple sclerosis patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Mustafa","family":"K\u0131ranatl\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melike","family":"Yurtta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcjgan","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Canbaz Kabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"6","key":"4007_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","volume":"31","author":"J Oh","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31(6):752\u20139.","journal-title":"Curr Opin Neurol"},{"issue":"1-2","key":"4007_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2011.03.003","volume":"234","author":"JM Greer","year":"2011","unstructured":"Greer JM, McCombe PA. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol. 2011;234(1-2):7\u201318.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"4007_CR3","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444.","journal-title":"Neurology"},{"issue":"1","key":"4007_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000440980","volume":"25","author":"H Hatipoglu","year":"2016","unstructured":"Hatipoglu H, Kabay SC, Hatipoglu MG, Ozden H. Expanded disability status scale-based disability and dental-periodontal conditions in patients with multiple sclerosis. Med Princ Pract. 2016;25(1):49\u201355.","journal-title":"Med Princ Pract"},{"issue":"11","key":"4007_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/TCRM.S76282","volume":"22","author":"A Villa","year":"2014","unstructured":"Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2014;22(11):45\u201351.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"4007_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.17219\/dmp\/112576","volume":"57","author":"H Mortazavi","year":"2020","unstructured":"Mortazavi H, Akbari M, Sahraian MA, Jahromi AA, Shafiei S. Salivary profile and dental status of patients with multiple sclerosis. Dent Med Probl. 2020;57(1):25\u20139.","journal-title":"Dent Med Probl"},{"issue":"5","key":"4007_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/sj.bdj.4800255a","volume":"187","author":"C McGrother","year":"1999","unstructured":"McGrother C, Dugmore C, Phillips M, Raymond N, Garrick P, Baird W. Multiple sclerosis, dental caries and fillings: a case-control study. British Dent J. 1999;187(5):261\u20134.","journal-title":"British Dent J"},{"issue":"Suppl 3","key":"4007_CR8","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.21037\/gs.2019.05.03","volume":"8","author":"M Carotti","year":"2019","unstructured":"Carotti M, Salaffi F, Di Carlo M, Barile A, Giovagnoni A. Diagnostic value of major salivary gland ultrasonography in primary Sj\u00f6gren\u2019s syndrome: the role of grey-scale and colour\/power Doppler sonography. Gland Surg. 2019;8(Suppl 3):S159\u201367.","journal-title":"Gland Surg"},{"key":"4007_CR9","doi-asserted-by":"crossref","unstructured":"Orhan K. Introduction to ultrasonography in Dentomaxillofacial imaging. In: Kaan O, editor. Ultrasonography in Dentomaxillofacial Diagnostics. Switzerland, Springer; 2021. p. 1\u20135.","DOI":"10.1007\/978-3-030-62179-7_1"},{"key":"4007_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-030-62179-7_9","volume-title":"Ultrasonography in Dentomaxillofacial Diagnostics","author":"A Delantoni","year":"2021","unstructured":"Delantoni A. Sonographic Anatomy and Pathology Salivary Glands. In: Kaan O, editor. Ultrasonography in Dentomaxillofacial Diagnostics. Switzerland: Springer; 2021. p. 109\u201324."},{"issue":"4","key":"4007_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4103\/jmu.jmu_144_21","volume":"29","author":"PH Huang","year":"2021","unstructured":"Huang PH, Chen DY. Diagnostic value of the salivary gland ultrasonography scoring system in patients with primary Sjogren's syndrome. J Med Ultrasound. 2021;29(4):235\u20136.","journal-title":"J Med Ultrasound"},{"issue":"9648","key":"4007_CR12","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502\u201317.","journal-title":"Lancet"},{"issue":"4","key":"4007_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285613488434","volume":"6","author":"HF Harbo","year":"2013","unstructured":"Harbo HF, Gold R, Tintor\u00e9 M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013;6(4):237\u201348.","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"4007_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jdent.2004.10.009","volume":"33","author":"MW Dodds","year":"2005","unstructured":"Dodds MW, Johnson DA, Yeh C-K. Health benefits of saliva: a review. J Dent. 2005;33(3):223\u201333.","journal-title":"J Dent"},{"issue":"1","key":"4007_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/B:MCBI.0000028748.40917.6f","volume":"261","author":"AD Mata","year":"2004","unstructured":"Mata AD, Marques D, Rocha S, Francisco H, Santos C, Mesquita MF, et al. Effects of diabetes mellitus on salivary secretion and its composition in the human. Mol Cell Biochem. 2004;261(1):137\u201342.","journal-title":"Mol Cell Biochem"},{"key":"4007_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2017.05.009","volume":"188","author":"X Qi","year":"2017","unstructured":"Qi X, Sun C, Tian Y, Han Y, Peng C, Jin H, et al. Comparison of the diagnostic value of four scoring systems in primary sj\u00f6gren's syndrome patients. Immunol Lett. 2017;188:9\u201312.","journal-title":"Immunol Lett"},{"issue":"1","key":"4007_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13075-021-02689-3","volume":"23","author":"X Zhang","year":"2021","unstructured":"Zhang X, Feng R, Zhao J, Wang Y, He J, Liu L, et al. Salivary gland ultrasonography in primary Sj\u00f6gren's syndrome from diagnosis to clinical stratification: a multicentre study. Arthritis Res Ther. 2021;23(1):305.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"4007_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/rheumatology\/kev103","volume":"54","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhang S, He J, Hu F, Liu H, Li J, et al. Ultrasonographic evaluation of major salivary glands in primary Sj\u00f6gren's syndrome: comparison of two scoring systems. Rheumatology (Oxford). 2015;54(9):1680\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 112","key":"4007_CR19","first-page":"165","volume":"36","author":"K-A Lee","year":"2018","unstructured":"Lee K-A, Lee S-H, Kim H-R. Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2018;36(Suppl 112):165\u201372.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"4007_CR20","doi-asserted-by":"publisher","first-page":"105113","DOI":"10.1016\/j.jbspin.2020.105113","volume":"88","author":"KA Lee","year":"2021","unstructured":"Lee KA, Choi W, Kim J, Kim HS. High prevalence of salivary gland ultrasound abnormalities in systemic sclerosis. Joint Bone Spine. 2021;88(2):105113.","journal-title":"Joint Bone Spine"},{"issue":"3","key":"4007_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.11152\/mu-2164","volume":"21","author":"M Badarinza","year":"2019","unstructured":"Badarinza M, Serban O, Maghear L, Bocsa C, Micu M, Porojan MD, et al. Multimodal ultrasound investigation (grey scale, Doppler and 2D-SWE) of salivary and lacrimal glands in healthy people and patients with diabetes mellitus and\/or obesity, with or without sialosis. Med Ultrason. 2019;21(3):257\u201364.","journal-title":"Med Ultrason"},{"key":"4007_CR22","doi-asserted-by":"publisher","first-page":"103783","DOI":"10.1016\/j.msard.2022.103783","volume":"62","author":"JSI Hora","year":"2022","unstructured":"Hora JSI, da Silva MCR, Braga CLS, Loureiro AM, Alves ATNN, Louren\u00e7o SQC, et al. Dry oral and ocular manifestations and autoantibodies characteristic of primary Sj\u00f6gren's syndrome in multiple sclerosis. Mult Scler Relat Disord. 2022;62:103783.","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"4007_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.autrev.2016.01.013","volume":"15","author":"G Masi","year":"2016","unstructured":"Masi G, Annunziata P. Sj\u00f6gren's syndrome and multiple sclerosis: two sides of the same coin? Autoimmun Rev. 2016;15(5):457\u201361.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4007_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.msard.2015.09.001","volume":"4","author":"AO Dulamea","year":"2015","unstructured":"Dulamea AO, Boscaiu V, Sava MM. Disability status and dental pathology in multiple sclerosis patients. Mult Scler Relat Disord. 2015;4(6):567\u201371.","journal-title":"Mult Scler Relat Disord"},{"key":"4007_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jprot.2018.07.019","volume":"187","author":"B Manconi","year":"2018","unstructured":"Manconi B, Liori B, Cabras T, Vincenzoni F, Iavarone F, Lorefice L, et al. Top-down proteomic profiling of human saliva in multiple sclerosis patients. J Proteome. 2018;187:212\u201322.","journal-title":"J Proteome"},{"issue":"3","key":"4007_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1754-4505.1993.tb01627.x","volume":"13","author":"AL Symons","year":"1993","unstructured":"Symons AL, Bortolanza M, Godden S, Seymour G. A preliminary study into the dental health status of multiple sclerosis patients. Spec Care Dentist. 1993;13(3):96\u2013101.","journal-title":"Spec Care Dentist"},{"issue":"2","key":"4007_CR27","first-page":"441","volume":"29","author":"Z Kova\u010d","year":"2005","unstructured":"Kova\u010d Z, Uha\u010d I, Bukovi\u0107 D, \u0106abov T, Kova\u010devi\u0107 D, Gr\u017ei\u0107 R. Oral health status and temporomandibular disorders in multiple sclerosis patients. Coll Antropol. 2005;29(2):441\u20134.","journal-title":"Coll Antropol"},{"key":"4007_CR28","unstructured":"Tavanga A, Etemadifar M, Emamjomeh M, Mojtahedi N. Dental amalgam and multiple sclerosis: a case-control study. Oral Maxillofac Pathol J. 2018;9(1)"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-024-04007-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-024-04007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T08:03:24Z","timestamp":1708070604000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-024-04007-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4007"],"URL":"https:\/\/doi.org\/10.1186\/s12903-024-04007-0","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"2 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the K\u00fctahya Health Sciences University Clinical Research Ethics Committee with the decision dated 16.11.2021 and numbered 2021-07\/03. Informed consent was obtained from the individuals participating in the study in accordance with the Helsinki Declaration decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}